Patent №
US 11,246,990
Granted
2022-02-15
Filed 2018
Owner
DEXCOM, INC.
Lab
—
AI components
2
planning · evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15906946
Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
AI classification
Ownership
DEXCOM, INC.
assignment · 466160911
Assignors
BRAUKER, JAMES H, TAPSAK, MARK A, SAINT, SEAN T, KAMATH, APURV U, NEALE, PAUL V, SIMPSON, PETER C, MENSINGER, MICHAEL R, MARKOVIC, DUBRAVKA
On an employer assignment, the assignors are typically the inventors.